Lilly and Amylin clarify Byetta pancreatitis risk
This article was originally published in Scrip
Executive Summary
Six patients who have received Lillyand Amylin's injectable type 2 diabetes drug Byetta (exenatide) and who have also had pancreatitis have died so far, the companies have revealed in a conference call.